Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study

Objective. To describe our institution’s experience with the AngioVac system. Background. Intracardiac and intravascular masses previously required surgical excision, but now, there are a number of minimally invasive options. With the advent of vacuum aspiration, more specifically the AngioVac Syste...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Aashish Katapadi, Lauren Richards, William Fischer, Suhail Q. Allaqaband, Tanvir Bajwa, M. Fuad Jan
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi-Wiley 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/50cfedfc9d3642d6aac09563bc8fc1f4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:50cfedfc9d3642d6aac09563bc8fc1f4
record_format	dspace
spelling	oai:doaj.org-article:50cfedfc9d3642d6aac09563bc8fc1f42021-11-08T02:35:56ZEndovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study1540-818310.1155/2021/9923440https://doaj.org/article/50cfedfc9d3642d6aac09563bc8fc1f42021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/9923440https://doaj.org/toc/1540-8183Objective. To describe our institution’s experience with the AngioVac system. Background. Intracardiac and intravascular masses previously required surgical excision, but now, there are a number of minimally invasive options. With the advent of vacuum aspiration, more specifically the AngioVac System (AngioDynamics, NY, USA), there exists a system with both low mortality and minor complications. However, the number of retrospective studies remains limited. Outcome data for high-risk patients are also limited. Methods. Data were collected and analyzed in patients who underwent AngioVac therapy at our tertiary care center from January 2014 to December 2020. Results. Our results demonstrated a 93.3% intraoperative success rate and a 100% intraoperative survival rate. However, a number of complications, including but not limited to hematomas, anemia, and hypotension, occurred, as described below. Conclusions. Our experiences demonstrated good outcomes and continue to support the usefulness of the AngioVac System. The data also support the use of AngioVac as a treatment option for the debulking or removal of right heart masses in critically ill patients.Aashish KatapadiLauren RichardsWilliam FischerSuhail Q. AllaqabandTanvir BajwaM. Fuad JanHindawi-WileyarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENJournal of Interventional Cardiology, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Aashish Katapadi Lauren Richards William Fischer Suhail Q. Allaqaband Tanvir Bajwa M. Fuad Jan Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study
description	Objective. To describe our institution’s experience with the AngioVac system. Background. Intracardiac and intravascular masses previously required surgical excision, but now, there are a number of minimally invasive options. With the advent of vacuum aspiration, more specifically the AngioVac System (AngioDynamics, NY, USA), there exists a system with both low mortality and minor complications. However, the number of retrospective studies remains limited. Outcome data for high-risk patients are also limited. Methods. Data were collected and analyzed in patients who underwent AngioVac therapy at our tertiary care center from January 2014 to December 2020. Results. Our results demonstrated a 93.3% intraoperative success rate and a 100% intraoperative survival rate. However, a number of complications, including but not limited to hematomas, anemia, and hypotension, occurred, as described below. Conclusions. Our experiences demonstrated good outcomes and continue to support the usefulness of the AngioVac System. The data also support the use of AngioVac as a treatment option for the debulking or removal of right heart masses in critically ill patients.
format	article
author	Aashish Katapadi Lauren Richards William Fischer Suhail Q. Allaqaband Tanvir Bajwa M. Fuad Jan
author_facet	Aashish Katapadi Lauren Richards William Fischer Suhail Q. Allaqaband Tanvir Bajwa M. Fuad Jan
author_sort	Aashish Katapadi
title	Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study
title_short	Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study
title_full	Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study
title_fullStr	Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study
title_full_unstemmed	Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study
title_sort	endovascular treatment of right heart masses utilizing the angiovac system: a 6-year single-center observational study
publisher	Hindawi-Wiley
publishDate	2021
url	https://doaj.org/article/50cfedfc9d3642d6aac09563bc8fc1f4
work_keys_str_mv	AT aashishkatapadi endovasculartreatmentofrightheartmassesutilizingtheangiovacsystema6yearsinglecenterobservationalstudy AT laurenrichards endovasculartreatmentofrightheartmassesutilizingtheangiovacsystema6yearsinglecenterobservationalstudy AT williamfischer endovasculartreatmentofrightheartmassesutilizingtheangiovacsystema6yearsinglecenterobservationalstudy AT suhailqallaqaband endovasculartreatmentofrightheartmassesutilizingtheangiovacsystema6yearsinglecenterobservationalstudy AT tanvirbajwa endovasculartreatmentofrightheartmassesutilizingtheangiovacsystema6yearsinglecenterobservationalstudy AT mfuadjan endovasculartreatmentofrightheartmassesutilizingtheangiovacsystema6yearsinglecenterobservationalstudy
_version_	1718443182621982720

Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study

Ejemplares similares